Last 12 months
Inside the activity.
0 purchase rows · 158 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 26 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 27 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 31 |
| Sep 2026 | 0 | 48 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2025 Filed Sep 4, 2025 23:05 UTC |
Anders JackChief Financial Officer
|
Exercise / conversionCommon Stock | 2,814 | $2.68 | $7,541.52 |
DisclosureSEC source: 0001610717-25-000326 · form4.xml · nonDerivative · entry 1 Anders Jack · CIK 0001800668 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 116,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024. F2 · balance_after: Includes 54,213 RSUs. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:11 UTC |
GOLDSMITH MARK ADirector · See Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 37,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001610717-25-000274 · form4.xml · derivative · entry 5 GOLDSMITH MARK A · CIK 0001246842 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,503 Underlying: Common Stock · 37,000 shares Expires 2028-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 20:11 UTC |
GOLDSMITH MARK ADirector · See Remarks
|
Exercise / conversionCommon Stock | 37,000 | $0.54 | $19,980.00 |
DisclosureSEC source: 0001610717-25-000274 · form4.xml · nonDerivative · entry 1 GOLDSMITH MARK A · CIK 0001246842 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 218,188 restricted stock units. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:27 UTC |
Patel SushilDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,574 | $0.00 Strike: $37.48 | $0.00 |
DisclosureSEC source: 0001610717-25-000272 · form4.xml · derivative · entry 2 Patel Sushil · CIK 0001860609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,574 Underlying: Common Stock · 11,574 shares Expires 2035-06-26 F2 · derivative.exercise_date: Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:27 UTC |
Patel SushilDirector
|
GrantCommon Stock | 3,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000272 · form4.xml · nonDerivative · entry 1 Patel Sushil · CIK 0001860609 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,090 F1 · acquired: Includes 4,017 Restricted Stock Units. F1 · balance_after: Includes 4,017 Restricted Stock Units. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:27 UTC |
Horning SandraDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,574 | $0.00 Strike: $37.48 | $0.00 |
DisclosureSEC source: 0001610717-25-000273 · form4.xml · derivative · entry 2 Horning Sandra · CIK 0001638709 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,574 Underlying: Common Stock · 11,574 shares Expires 2035-06-26 F2 · derivative.exercise_date: Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:27 UTC |
Horning SandraDirector
|
GrantCommon Stock | 3,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000273 · form4.xml · nonDerivative · entry 1 Horning Sandra · CIK 0001638709 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,574 F1 · balance_after: Includes 8,392 Restricted Stock Units. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:25 UTC |
Borisy AlexisDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,574 | $0.00 Strike: $37.48 | $0.00 |
DisclosureSEC source: 0001610717-25-000270 · form4.xml · derivative · entry 2 Borisy Alexis · CIK 0001319446 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,574 Underlying: Common Stock · 11,574 shares Expires 2035-06-26 F2 · derivative.exercise_date: Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:25 UTC |
Borisy AlexisDirector
|
GrantCommon Stock | 3,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000270 · form4.xml · nonDerivative · entry 1 Borisy Alexis · CIK 0001319446 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,338,884 F1 · balance_after: Includes 3,142 Restricted Stock Units. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:25 UTC |
Kim Lorence H.Director
|
GrantStock Option (Right to Buy) · Derivative | 11,574 | $0.00 Strike: $37.48 | $0.00 |
DisclosureSEC source: 0001610717-25-000271 · form4.xml · derivative · entry 2 Kim Lorence H. · CIK 0001643746 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,574 Underlying: Common Stock · 11,574 shares Expires 2035-06-26 F2 · derivative.exercise_date: Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:25 UTC |
Kim Lorence H.Director
|
GrantCommon Stock | 3,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000271 · form4.xml · nonDerivative · entry 1 Kim Lorence H. · CIK 0001643746 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,090 F1 · balance_after: Includes 4,017 Restricted Stock Units. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:24 UTC |
Borellini FlaviaDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,574 | $0.00 Strike: $37.48 | $0.00 |
DisclosureSEC source: 0001610717-25-000269 · form4.xml · derivative · entry 2 Borellini Flavia · CIK 0001867426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,574 Underlying: Common Stock · 11,574 shares Expires 2035-06-26 F2 · derivative.exercise_date: Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:24 UTC |
Borellini FlaviaDirector
|
GrantCommon Stock | 3,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000269 · form4.xml · nonDerivative · entry 1 Borellini Flavia · CIK 0001867426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,024 F1 · balance_after: Includes 3,142 Restricted Stock Units. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:24 UTC |
ANDERSON ELIZABETH MDirector
|
GrantStock Option (Right to Buy) · Derivative | 11,574 | $0.00 Strike: $37.48 | $0.00 |
DisclosureSEC source: 0001610717-25-000268 · form4.xml · derivative · entry 3 ANDERSON ELIZABETH M · CIK 0001758247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,574 Underlying: Common Stock · 11,574 shares Expires 2035-06-26 F3 · derivative.exercise_date: Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:24 UTC |
ANDERSON ELIZABETH MDirector
|
GrantCommon Stock | 3,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000268 · form4.xml · nonDerivative · entry 2 ANDERSON ELIZABETH M · CIK 0001758247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,215 F2 · balance_after: Includes 3,142 Restricted Stock Units. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:23 UTC |
Clyburn FrankDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,337 | $0.00 Strike: $37.48 | $0.00 |
DisclosureSEC source: 0001610717-25-000267 · form4.xml · derivative · entry 2 Clyburn Frank · CIK 0001763963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,337 Underlying: Common Stock · 10,337 shares Expires 2035-06-26 F2 · derivative.exercise_date: Shares subject to the Option shall vest in full on the earlier of (i) the first anniversary of June 26, 2025 or (ii) immediately prior to the Annual Meeting following the date of grant subject to the Reporting Person remaining a Service Provider (as defined in the 2020 Plan) through the vesting date. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 20:23 UTC |
Clyburn FrankDirector
|
GrantCommon Stock | 2,806 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000267 · form4.xml · nonDerivative · entry 1 Clyburn Frank · CIK 0001763963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,738 F1 · balance_after: Includes 8,005 Restricted Stock Units. Read SEC document |
| June 20, 2025 Filed Jun 23, 2025 20:07 UTC |
Cislini JeffGeneral Counsel
|
SaleCommon Stock | 1,912 | $39.61 | $75,735.85 |
DisclosureSEC source: 0001610717-25-000250 · form4.xml · nonDerivative · entry 1 Cislini Jeff · CIK 0001969082 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,093 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. F2 · price: This transaction was executed in multiple trades in prices ranging from $39.26 to $40.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 49,054 restricted stock units. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:05 UTC |
Anders JackChief Financial Officer
|
SaleCommon Stock | 2,170 | $39.83 | $86,431.10 |
DisclosureSEC source: 0001610717-25-000239 · form4.xml · nonDerivative · entry 1 Anders Jack · CIK 0001800668 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,314 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $39.5913 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 478 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025. F4 · balance_after: Includes 54,213 RSUs. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:05 UTC |
Kelsey Stephen MichaelSee Remarks
|
SaleCommon Stock | 4,289 | $39.83 | $170,830.87 |
DisclosureSEC source: 0001610717-25-000238 · form4.xml · nonDerivative · entry 1 Kelsey Stephen Michael · CIK 0001462808 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 289,414 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $39.6017 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025. F4 · balance_after: Includes 94,426 RSUs. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:06 UTC |
Horn Margaret AChief Operating Officer
|
SaleCommon Stock | 3,510 | $39.83 | $139,803.30 |
DisclosureSEC source: 0001610717-25-000242 · form4.xml · nonDerivative · entry 1 Horn Margaret A · CIK 0001294192 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,675 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $39.6017 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025. F4 · balance_after: Includes 79,776 RSUs. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:06 UTC |
GOLDSMITH MARK ADirector · See Remarks
|
SaleCommon Stock | 13,496 | $39.83 | $537,545.68 |
DisclosureSEC source: 0001610717-25-000241 · form4.xml · nonDerivative · entry 1 GOLDSMITH MARK A · CIK 0001246842 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 428,720 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $39.6016 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025. F4 · balance_after: Includes 218,188 RSUs. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:06 UTC |
Cislini JeffGeneral Counsel
|
SaleCommon Stock | 1,878 | $39.83 | $74,800.74 |
DisclosureSEC source: 0001610717-25-000240 · form4.xml · nonDerivative · entry 1 Cislini Jeff · CIK 0001969082 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,005 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $39.5915 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 160 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025. F4 · balance_after: Includes 49,054 RSUs. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:05 UTC |
Wei LinChief Medical Officer
|
SaleCommon Stock | 2,173 | $39.83 | $86,550.59 |
DisclosureSEC source: 0001610717-25-000237 · form4.xml · nonDerivative · entry 1 Wei Lin · CIK 0001872772 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,499 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on December 23, 2024 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after March 15, 2025. F2 · price: This transaction was executed in multiple trades in prices ranging from $39.6017 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 1,021 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025. F4 · balance_after: Includes 64,800 RSUs. Read SEC document |
| June 16, 2025 Filed Jun 17, 2026 23:51 UTC |
Horn Margaret AChief Operating Officer
|
SaleCommon Stock | 3,575 | $156.12 | $558,126.50 |
DisclosureSEC source: 0001610717-26-000230 · form4.xml · nonDerivative · entry 4 Horn Margaret A · CIK 0001294192 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,647 F4 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of RSUs after July 15, 2023. F5 · price: This transaction was executed in multiple trades in prices ranging from $156.1105 to $156.8250, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F6 · balance_after: Includes 66,201 RSUs. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 20:55 UTC |
Cislini JeffGeneral Counsel
|
SaleCommon Stock | 2,041 | $38.71 | $79,008.13 |
DisclosureSEC source: 0001610717-25-000088 · form4.xml · nonDerivative · entry 1 Cislini Jeff · CIK 0001969082 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,723 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024. F2 · price: This transaction was executed in multiple trades in prices ranging from $38.49 to $38.91, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 54,195 restricted stock units. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 17:40 UTC |
Wang XiaolinSee Remarks
|
GiftCommon Stock | 2,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000076 · form4.xml · nonDerivative · entry 1 Wang Xiaolin · CIK 0001849181 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,321 F1 · balance_after: Includes 56,650 restricted stock units. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 21:42 UTC |
Anders JackChief Financial Officer
|
SaleCommon Stock | 1,864 | $39.04 | $72,771.12 |
DisclosureSEC source: 0001610717-25-000079 · form4.xml · nonDerivative · entry 1 Anders Jack · CIK 0001800668 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,006 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · balance_after: Includes 60,150 RSUs. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 21:40 UTC |
Kelsey Stephen MichaelSee Remarks
|
SaleCommon Stock | 3,294 | $39.04 | $128,598.75 |
DisclosureSEC source: 0001610717-25-000077 · form4.xml · nonDerivative · entry 1 Kelsey Stephen Michael · CIK 0001462808 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 293,051 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · balance_after: Includes 104,850 RSUs. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 21:41 UTC |
Horn Margaret AChief Operating Officer
|
SaleCommon Stock | 3,058 | $39.04 | $119,385.24 |
DisclosureSEC source: 0001610717-25-000078 · form4.xml · nonDerivative · entry 1 Horn Margaret A · CIK 0001294192 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,533 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · balance_after: Includes 89,050 RSUs. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 21:43 UTC |
GOLDSMITH MARK ADirector · See Remarks
|
SaleCommon Stock | 11,738 | $39.04 | $458,255.04 |
DisclosureSEC source: 0001610717-25-000080 · form4.xml · nonDerivative · entry 1 GOLDSMITH MARK A · CIK 0001246842 · Director · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 441,564 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · balance_after: Includes 242,900 RSUs. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 21:43 UTC |
Cislini JeffGeneral Counsel
|
SaleCommon Stock | 1,458 | $39.04 | $56,920.76 |
DisclosureSEC source: 0001610717-25-000081 · form4.xml · nonDerivative · entry 1 Cislini Jeff · CIK 0001969082 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,764 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · balance_after: Includes 54,195 RSUs. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 19:01 UTC |
Wang XiaolinSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 66,500 | $0.00 Strike: $40.74 | $0.00 |
DisclosureSEC source: 0001610717-25-000051 · form4.xml · derivative · entry 2 Wang Xiaolin · CIK 0001849181 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,500 Underlying: Common Stock · 66,500 shares Expires 2035-02-28 F3 · derivative.exercise_date: One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 19:01 UTC |
Wang XiaolinSee Remarks
|
GrantCommon Stock | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000051 · form4.xml · nonDerivative · entry 1 Wang Xiaolin · CIK 0001849181 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,039 F1 · balance_after: Includes 61,926 restricted stock units. F2 · balance_after: Includes 1,513 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2024. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:02 UTC |
Anders JackChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 71,400 | $0.00 Strike: $40.74 | $0.00 |
DisclosureSEC source: 0001610717-25-000055 · form4.xml · derivative · entry 2 Anders Jack · CIK 0001800668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,400 Underlying: Common Stock · 71,400 shares Expires 2035-02-28 F2 · derivative.exercise_date: One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:02 UTC |
Anders JackChief Financial Officer
|
GrantCommon Stock | 20,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000055 · form4.xml · nonDerivative · entry 1 Anders Jack · CIK 0001800668 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,870 F1 · balance_after: Includes 65,276 restricted stock units. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:02 UTC |
Kelsey Stephen MichaelSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 128,100 | $0.00 Strike: $40.74 | $0.00 |
DisclosureSEC source: 0001610717-25-000054 · form4.xml · derivative · entry 2 Kelsey Stephen Michael · CIK 0001462808 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,100 Underlying: Common Stock · 128,100 shares Expires 2035-02-28 F2 · derivative.exercise_date: One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:02 UTC |
Kelsey Stephen MichaelSee Remarks
|
GrantCommon Stock | 36,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000054 · form4.xml · nonDerivative · entry 1 Kelsey Stephen Michael · CIK 0001462808 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 296,345 F1 · balance_after: Includes 113,926 restricted stock units. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:02 UTC |
Horn Margaret AChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,100 | $0.00 Strike: $40.74 | $0.00 |
DisclosureSEC source: 0001610717-25-000053 · form4.xml · derivative · entry 2 Horn Margaret A · CIK 0001294192 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,100 Underlying: Common Stock · 100,100 shares Expires 2035-02-28 F2 · derivative.exercise_date: One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:02 UTC |
Horn Margaret AChief Operating Officer
|
GrantCommon Stock | 28,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000053 · form4.xml · nonDerivative · entry 1 Horn Margaret A · CIK 0001294192 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,591 F1 · balance_after: Includes 97,476 restricted stock units. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:00 UTC |
GOLDSMITH MARK ADirector · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 341,100 | $0.00 Strike: $40.74 | $0.00 |
DisclosureSEC source: 0001610717-25-000050 · form4.xml · derivative · entry 5 GOLDSMITH MARK A · CIK 0001246842 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 341,100 shares Expires 2035-02-28 F5 · derivative.exercise_date: One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:00 UTC |
GOLDSMITH MARK ADirector · See Remarks
|
GrantCommon Stock | 97,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000050 · form4.xml · nonDerivative · entry 1 GOLDSMITH MARK A · CIK 0001246842 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,302 F1 · balance_after: Includes 264,525 restricted stock units. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:03 UTC |
Cislini JeffGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 77,000 | $0.00 Strike: $40.74 | $0.00 |
DisclosureSEC source: 0001610717-25-000056 · form4.xml · derivative · entry 2 Cislini Jeff · CIK 0001969082 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,000 Underlying: Common Stock · 77,000 shares Expires 2035-02-28 F2 · derivative.exercise_date: One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:03 UTC |
Cislini JeffGeneral Counsel
|
GrantCommon Stock | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000056 · form4.xml · nonDerivative · entry 1 Cislini Jeff · CIK 0001969082 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,222 F1 · balance_after: Includes 58,204 restricted stock units. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:01 UTC |
Wei LinChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 72,800 | $0.00 Strike: $40.74 | $0.00 |
DisclosureSEC source: 0001610717-25-000052 · form4.xml · derivative · entry 2 Wei Lin · CIK 0001872772 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,800 Underlying: Common Stock · 72,800 shares Expires 2035-02-28 F2 · derivative.exercise_date: One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 00:01 UTC |
Wei LinChief Medical Officer
|
GrantCommon Stock | 20,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-25-000052 · form4.xml · nonDerivative · entry 1 Wei Lin · CIK 0001872772 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,651 F1 · balance_after: Includes 70,750 restricted stock units. Read SEC document |
| January 21, 2025 Filed Jan 22, 2025 22:30 UTC |
Cislini JeffGeneral Counsel
|
SaleCommon Stock | 2,406 | $40.50 | $97,443.00 |
DisclosureSEC source: 0001610717-25-000012 · form4.xml · nonDerivative · entry 1 Cislini Jeff · CIK 0001969082 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,222 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024. F2 · balance_after: Includes 36,204 restricted stock units. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 21:50 UTC |
GOLDSMITH MARK ADirector · See Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,846 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001610717-24-000548 · form4.xml · derivative · entry 5 GOLDSMITH MARK A · CIK 0001246842 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,846 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2024 Filed Dec 20, 2024 21:50 UTC |
GOLDSMITH MARK ADirector · See Remarks
|
Exercise / conversionCommon Stock | 30,846 | $0.49 | $15,114.54 |
DisclosureSEC source: 0001610717-24-000548 · form4.xml · nonDerivative · entry 1 GOLDSMITH MARK A · CIK 0001246842 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 167,125 restricted stock units. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:06 UTC |
Anders JackChief Financial Officer
|
SaleCommon Stock | 2,635 | $45.40 | $119,639.01 |
DisclosureSEC source: 0001610717-24-000543 · form4.xml · nonDerivative · entry 1 Anders Jack · CIK 0001800668 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,470 F1 · kind: Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023. F2 · balance_after: Includes 173 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2024. F3 · balance_after: Includes 44,876 RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.